<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 03 Sep 2025 08:30:37 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Oligomerix names William Caple as board chairman</title>
   <link>http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</link>
   <description>

&lt;p&gt;Oligomerix Inc., a clinical-stage biotechnology company developing treatments for neurodegenerative diseases, announced the election of William Caple as chairman of its board of directors.&lt;/p&gt;

&lt;p&gt;Caple brings over 30 years of executive leadership experience across multiple industries. He founded Caple Advisory Solutions, an international management consulting practice focused on growth, corporate finance, and business development. He currently serves on the board of Splash Beverage (NYSE American: SBEV) and is a member of The Livingston Group-Asia.&lt;/p&gt;

&lt;p&gt;His previous experience includes leading the initial public offering of software company OTG Software (NASDAQ: OTGS) and representing Korean private equity firm Centroid Investment Partners in the $1.8</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:37 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix names William Caple as board chairman</title>
   <link>http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</link>
   <description>

&lt;p&gt;Oligomerix Inc., a clinical-stage biotechnology company developing treatments for neurodegenerative diseases, announced the election of William Caple as chairman of its board of directors.&lt;/p&gt;

&lt;p&gt;Caple brings over 30 years of executive leadership experience across multiple industries. He founded Caple Advisory Solutions, an international management consulting practice focused on growth, corporate finance, and business development. He currently serves on the board of Splash Beverage (NYSE American: SBEV) and is a member of The Livingston Group-Asia.&lt;/p&gt;

&lt;p&gt;His previous experience includes leading the initial public offering of software company OTG Software (NASDAQ: OTGS) and representing Korean private equity firm Centroid Investment Partners in the $1.8</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:37 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix names William Caple as board chairman</title>
   <link>http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</link>
   <description>

&lt;p&gt;Oligomerix Inc., a clinical-stage biotechnology company developing treatments for neurodegenerative diseases, announced the election of William Caple as chairman of its board of directors.&lt;/p&gt;

&lt;p&gt;Caple brings over 30 years of executive leadership experience across multiple industries. He founded Caple Advisory Solutions, an international management consulting practice focused on growth, corporate finance, and business development. He currently serves on the board of Splash Beverage (NYSE American: SBEV) and is a member of The Livingston Group-Asia.&lt;/p&gt;

&lt;p&gt;His previous experience includes leading the initial public offering of software company OTG Software (NASDAQ: OTGS) and representing Korean private equity firm Centroid Investment Partners in the $1.8</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:37 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix names William Caple as board chairman</title>
   <link>http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</link>
   <description>

&lt;p&gt;Oligomerix Inc., a clinical-stage biotechnology company developing treatments for neurodegenerative diseases, announced the election of William Caple as chairman of its board of directors.&lt;/p&gt;

&lt;p&gt;Caple brings over 30 years of executive leadership experience across multiple industries. He founded Caple Advisory Solutions, an international management consulting practice focused on growth, corporate finance, and business development. He currently serves on the board of Splash Beverage (NYSE American: SBEV) and is a member of The Livingston Group-Asia.&lt;/p&gt;

&lt;p&gt;His previous experience includes leading the initial public offering of software company OTG Software (NASDAQ: OTGS) and representing Korean private equity firm Centroid Investment Partners in the $1.8</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:37 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix names William Caple as board chairman</title>
   <link>http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</link>
   <description>

&lt;p&gt;Oligomerix Inc., a clinical-stage biotechnology company developing treatments for neurodegenerative diseases, announced the election of William Caple as chairman of its board of directors.&lt;/p&gt;

&lt;p&gt;Caple brings over 30 years of executive leadership experience across multiple industries. He founded Caple Advisory Solutions, an international management consulting practice focused on growth, corporate finance, and business development. He currently serves on the board of Splash Beverage (NYSE American: SBEV) and is a member of The Livingston Group-Asia.&lt;/p&gt;

&lt;p&gt;His previous experience includes leading the initial public offering of software company OTG Software (NASDAQ: OTGS) and representing Korean private equity firm Centroid Investment Partners in the $1.8</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:37 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix names William Caple as board chairman</title>
   <link>http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</link>
   <description>

&lt;p&gt;Oligomerix Inc., a clinical-stage biotechnology company developing treatments for neurodegenerative diseases, announced the election of William Caple as chairman of its board of directors.&lt;/p&gt;

&lt;p&gt;Caple brings over 30 years of executive leadership experience across multiple industries. He founded Caple Advisory Solutions, an international management consulting practice focused on growth, corporate finance, and business development. He currently serves on the board of Splash Beverage (NYSE American: SBEV) and is a member of The Livingston Group-Asia.&lt;/p&gt;

&lt;p&gt;His previous experience includes leading the initial public offering of software company OTG Software (NASDAQ: OTGS) and representing Korean private equity firm Centroid Investment Partners in the $1.8</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Oligomerix+names+William+Caple+as+board+chairman/25288998.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:37 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
  <item>
   <title>Oligomerix Elects New Chairman William Caple to Board of Directors</title>
   <link>http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</link>
   <description>
&lt;p&gt;    BRONX, N.Y.--(BUSINESS WIRE)--
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the election of William Caple as its new Chairman of the Board of Directors.

&lt;/p&gt;&lt;p&gt;
“Oligomerix is extremely pleased to announce the election of Bill Caple as its new Chairman of the Board. Bill brings extensive experience to our Board with his broad and diverse business experience, especially in helping to secure corporate investment and accelerate organizations’ business plans, which is precisely what Oligomerix needs at this stage of development,” said Doug Durand,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Oligomerix+Elects+New+Chairman+William+Caple+to+Board+of+Directors/25288958.html</guid>
   <pubDate>Wed, 03 Sep 2025 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19298212</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40361998</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OTGS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SBEV</category>
   	  </item>
 </channel>
</rss>
